DocuSign, Inc. DOCU shares are trading higher Friday after the company posted better-than-expected second-quarter results after the close of trading on Thursday.
The Details:
DocuSign beat analyst expectations on the top and bottom lines for the quarter and raised its fiscal year 2025 revenue guidance to a range of $2.94 billion to $2.952 billion.
"DocuSign continued its evolution with improved business stability and increased efficiency, resulting in record operating profit," said Allan Thygesen, CEO of DocuSign.
Read Next: What’s Going On With Celsius Holdings Stock?
Multiple analysts updated coverage on DocuSign following the print:
According to data from Benzinga Pro, DocuSign shares are moving on heavy trading volume above the stock’s 50-day moving average of $55.14.
Is DOCU A Good Stock To Buy?
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like DocuSign‘s page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
These are known as capital allocation programs. DocuSign does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on DocuSign will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
DOCU Price Action: According to Benzinga Pro, Docusign shares are up 3.86% at $59.13 at the time of publication Friday.
Read Also:
Image: Courtesy of DocuSign, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.